• 首页期刊简介编委会刊物订阅专栏专刊电子刊广告合作联系我们English
引用本文:董广金,王洪光.枸橼酸钾凝胶骨架缓释丸体外释放的影响因素研究[J].中国现代应用药学,2009,(6):475-477.
DONG Guangjin,WANG Hongguang.Factors Influencing the Release of Potassium Citrate Gel Matrix Sustained-release Pill in Vitro[J].Chin J Mod Appl Pharm(中国现代应用药学),2009,(6):475-477.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1979次   下载 1571 本文二维码信息
码上扫一扫!
分享到: 微信 更多
枸橼酸钾凝胶骨架缓释丸体外释放的影响因素研究
董广金,王洪光
作者单位
董广金,王洪光  
摘要:
目的 自制枸橼酸钾凝胶骨架缓释丸,考察影响其体外释放度的处方和工艺因素。方法 实验采用硫酸铜比色法测定枸橼酸钾含量,研究不同型号、不同黏度的HPMC、丸剂大小及压力大小对药物释放的影响。结果 该缓释微丸的体外释放度与美国药典对枸橼酸钾缓释片体外释放度的相关要求相符。结论 该剂型可以作为缓释片的替代剂型用于相关疾病的治疗。
关键词:  枸橼酸钾  体外释放度  羟丙基甲基纤维素
DOI:
分类号:
基金项目:
Factors Influencing the Release of Potassium Citrate Gel Matrix Sustained-release Pill in Vitro
DONG Guangjin,WANG Hongguang
Abstract:
OBJECTIVE To investigate the formulated and technological factors that influence the release of potassium citrate gel matrix sustained-release pill. METHODS The factors which include different models and different viscosity of HPMC, the size of pills and production pressure were investigated by determining the content of postassium citrate in potassium citrate solution using the UV spectrophortometry. RESULTS The release of sustained-release pills in vitro was in line with of the requirements of USP for the potassium citrate extended-release tablets. CONCLUSION The formulations can be used as alternative formulations for the treatment of related diseases.
Key words:  potassium citrate  release rate in vitro  HPMC
扫一扫关注本刊微信